Pharma

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

The New Reality for Pharma Marketers is Drug Pricing

The New Reality for Pharma Marketers is Drug Pricing

By

My hope is that all of us do a better job of focusing on value.

Gilead's Meyers on making deals and finding unmet patient needs

Gilead's Meyers on making deals and finding unmet patient needs

By

The drugmaker's new EVP of worldwide commercial operations also talks about tackling medication access, product launches, and starting a commercial team from scratch.

Five things for pharma marketers to know: Monday, November 28, 2016

Five things for pharma marketers to know: Monday, November 28, 2016

By

J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe

Five things for pharma marketers to know: Thursday, November 17, 2016

Five things for pharma marketers to know: Thursday, November 17, 2016

By

Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia

Will he or won't he? Pharma speculates on President-elect Trump

Will he or won't he? Pharma speculates on President-elect Trump

By

If Trump decides to go after pharma, politicians aren't likely to receive too many "How can you do this? Think about the children!" notes.

Changing Behavior is Ongoing, And That's Why It Requires Communications

Changing Behavior is Ongoing, And That's Why It Requires Communications

As humans, we trade in the credits and debits of good and bad behavior. We break diets, we resume smoking, we forget our medicine.

Five things for pharma marketers to know: Wednesday, November 9, 2016

Five things for pharma marketers to know: Wednesday, November 9, 2016

By

Trump, a critic and supporter of pharma, wins election; pharma's futures rise in election's wake; drug-pricing measure in California likely to be defeated

Infographic: what information doctors need from pharma

Infographic: what information doctors need from pharma

How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

Today's ambitious marketers and media people want to be the ones to not only figure out how to work within the regulations but also to create better work than ever before.

Five things for pharma marketers to know: Thursday, November 3, 2016

Five things for pharma marketers to know: Thursday, November 3, 2016

By

Sprout investors sue Valeant; FDA raises safety concerns for Cempra's experimental pneumonia drug; NHS gets approval to prescribe eribulin to breast cancer patients

Five things for pharma marketers to know: Wednesday, November 2, 2016

Five things for pharma marketers to know: Wednesday, November 2, 2016

By

Valeant to sell stomach-drug business for $10 billion; Pfizer reports growth in third quarter; sales of hep.-C drugs drive revenue down for Gilead Sciences

Timeline of a crisis: How Mylan responded to the EpiPen controversy

Timeline of a crisis: How Mylan responded to the EpiPen controversy

By

Mylan was slammed by people unable to afford its lifesaving EpiPen injection device following a price hike — its response was seen as too little, too late.

How We Picked the Health Influencer 50

How We Picked the Health Influencer 50

By

Each of this year's Influencers wields significant influence at a major health-related organization and boasts high-profile accomplishments, oftentimes ahead of the aforementioned pain-of- change curve.

Marvel creates superheroes suffering from bowel disease for Takeda campaign

Marvel creates superheroes suffering from bowel disease for Takeda campaign

By

Takeda launched four new superheroes whose lives have been touched by inflammatory bowel disease (IBD), with the help of PR agency Ketchum.

Astellas boosts pharma's rep with corporate branding push

Astellas boosts pharma's rep with corporate branding push

By

The new TV spot was developed with CNN and Edelman.

Drugmakers spar with FDA over proposed DTC animation study

Drugmakers spar with FDA over proposed DTC animation study

By

The FDA responded to criticism from industry about its proposed research of DTC animation.

Merck Consumer Health CMO on who makes healthcare decisions

Merck Consumer Health CMO on who makes healthcare decisions

By

Merck Consumer Health CMO Atilla Cansun also talks about about why the company is focused on preparing society for an average lifespan of 100 years.

Top 25 neurology products, based on 2016 sales forecasts

Top 25 neurology products, based on 2016 sales forecasts

MS drugs top the list, led by Teva's Copaxone, Biogen's Tecfida and Avonex, and Novartis' Gilenya.

Will Investors Reward Drugmakers That Limit Price Increases?

Will Investors Reward Drugmakers That Limit Price Increases?

By

Now here comes the big question. Will the shareholders and directors of KaloBios and Allergan reward or punish their CEOs for what some may see as revenue-capping concessions?

Why Excedrin embraced the headache of a contentious election season

Why Excedrin embraced the headache of a contentious election season

By

Excedrin's #DebateHeadache was inspired by complaints the brand noticed during the first presidential debate in September.

Cleveland Clinic's Cosgrove: Obamacare now 'part of the fabric' of the U.S.

Cleveland Clinic's Cosgrove: Obamacare now 'part of the fabric' of the U.S.

By

Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in

4 Ways Dwindling Pharma Sales Detailing Will Affect the Cloud

4 Ways Dwindling Pharma Sales Detailing Will Affect the Cloud

As the effectiveness of in-person detailing wanes, how will cloud-based content solutions adapt?

Pro ad report: All the data on journal spending in 1H 2016

Pro ad report: All the data on journal spending in 1H 2016

By

Ad pushes behind brands like Gilead Sciences' hepatitis-C pill Harvoni and Allergan's IBS drug Viberzi buoyed med-surg outlays for the first six months of 2016. Cancer drugs once again were the hottest category.

EvolveMKD picks up Merz's Mederma account

EvolveMKD picks up Merz's Mederma account

By

The firm will handle communications for scar treatment Mederma and is already managing the product launch of cellulite-treatment product Cellfina, the 10-year anniversary of injectable Radiesse, and introducing a product line.

Huntsworth Health promotes two to agency global CEOs

Huntsworth Health promotes two to agency global CEOs

By

The company promoted Maryellen Royle to global CEO of Tonic Life Communications and Jon Clark to global CEO of Nitrogen.

MM&M's 5 most popular stories in September 2016

MM&M's 5 most popular stories in September 2016

By

Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines

How five therapies changed the course of pharma history

How five therapies changed the course of pharma history

By

And why the stories behind thalidomide, Naprosyn, AZT, cardiology stents, and Zaltrap still resonate.

Merck's creative archive tells an industry story

Merck's creative archive tells an industry story

By

Did you know that Norman Rockwell was a medical illustrator for Merck?

OPINION

Email Newsletters